Bioforum Data Focused CRO Opens New Melbourne Office
Company provides local services for companies running R&D activities in Australia Bioforum – the Data Focused CRO and the leading Medidata partner in Israel, servicing research and academic institutes, pharma companies, CROs and startups locally and globally for…
Prota Therapeutics partners with world-leading bioscience company, Chr. Hansen
Prota Therapeutics partners with leading global bioscience company, Chr. Hansen, to progress the development of oral immunotherapies to treat food allergies. The partnership will assess the world’s best documented probiotic strain LGG® in a Phase III clinical trial…
Cancer Therapeutics CRC Appoints New CEO
Cancer Therapeutics CRC (CTX), a small molecule oncology drug discovery and development group partnered with some of Australia’s pre-eminent medical research institutions, is pleased to announce the appointment of Brett Carter as Chief Executive Officer. Brett will succeed…
Immutep Raises A$6.85M Through Institutional Placement
Read ASX Announcement Here • A$6.85m raised through share institutional placement to drive immuno-oncology development programs • Placement of new ordinary shares to leading Australian healthcare institutional investors Platinum Asset Management and Australian Ethical Investment, U.S. healthcare institutional…
Immutep Enters Into Clinical Trial Collaboration and Supply Agreement with MSD
Read ASX Announcement Here Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) has announced that it has entered into a clinical trial collaboration and supply agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as…
MTPConnect reports strong growth in Australia’s Medtech, Biotech and Pharmaceutical sector
MTPConnect – the Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – has released new sector metrics that show jobs supported by the MTP sector increased by 10% to 62,000 from 2015 to 2016, and that manufacturing…
New report aims to broaden understanding of how new medicines are funded in Australia
– Stakeholders debate future of medicines funding system at launch event A new report, developed by GlaxoSmithKline Australia (GSK) and ViiV Healthcare (ViiV) will be launched as part of an initiative to raise understanding of the medicines development…
QuickFire Challenge fuels medical innovation
The Victorian Government in collaboration with Johnson & Johnson Innovation JLABS today announced the Victorian QuickFire Challenge, a competition giving healthcare entrepreneurs the chance to transform their ground-breaking research into the products that will advance the well-being of people around…
Victorian Health Minister officially opens Johnson & Johnson Innovation Partnering Office at Monash University
The new Johnson & Johnson Innovation Partnering Office at Monash (JJIPO@MONASH) was officially opened today by the Victorian Health Minister, Jill Hennessy at Monash University in Clayton. The office will serve as Johnson & Johnson Innovation’s local base…
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products 4 December 2017, Melbourne: Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), is pleased to announce the signing of a non-exclusive license agreement with Rodan…
$2.5M GRANT AWARDED TO ADVANCE WOUNDVUE™ DEVELOPMENT
• Joint collaboration with University of Melbourne and Planet Innovation Adelaide, Australia, 7 December 2017: Australian medical technology company, LBT Innovations Limited (ASX:LBT) is pleased to announce it has been awarded a $2.513 million grant to advance the…
IDT Australia Executes API Development Agreement
• API Development Agreement executed with The State Government of Victoria • Total consideration over AUD 2,000,000 over the twelve month term of the project Australian pharmaceutical manufacturing and drug development company IDT Australia Limited (ASX:IDT) announces it…
